HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PD150606 protects against ischemia/reperfusion injury by preventing μ-calpain-induced mitochondrial apoptosis.

Abstract
Calpain plays an important role in myocardial ischemia/reperfusion (I/R) injury. PD150606, a nonpeptide, cell-permeable and noncompetitive calpain inhibitor, has been shown to have protective properties in ischemic disease. The aims of the present study were to investigate whether PD150606 could alleviate myocardial I/R injury and to examine the possible mechanisms involved. The I/R model was established in vivo in C57BL/6 mice and in vitro using neonatal mouse cardiomyocytes, respectively. To evaluate the protective effects of PD150606 on I/R injury, we measured the myocardial infarct area, apoptosis, and expression of cleaved caspase-3. We also investigated the underlying mechanisms by examining mitochondrial function as reflected by the ATP concentration, translocation of cytochrome c, dynamics of mPTP opening, and membrane potential (ΔΨm), coupled with calpain activity. Pretreatment with PD150606 significantly reduced the infarct area and apoptosis caused by I/R. PD150606 pretreatment also reduced mitochondrial dysfunction by inhibiting calpain activation. Moreover, we found that μ-calpain is the main contributor to I/R-induced calpain activation. Knockdown of μ-calpain with siRNA significantly reversed calpain activation, mitochondrial dysfunction, and cardiomyocyte apoptosis caused by I/R in vitro. Our results suggest that PD150606 may protect against I/R injury via preventing μ-calpain-induced mitochondrial apoptosis.
AuthorsTao Luo, Rongchuan Yue, Houxiang Hu, Zhou Zhou, Kai Hang Yiu, Shuang Zhang, Lei Xu, Ke Li, Zhengping Yu
JournalArchives of biochemistry and biophysics (Arch Biochem Biophys) Vol. 586 Pg. 1-9 (Nov 15 2015) ISSN: 1096-0384 [Electronic] United States
PMID26091952 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Acrylates
  • Cardiotonic Agents
  • Cysteine Proteinase Inhibitors
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • PD 150606
  • RNA, Small Interfering
  • Calpain
  • mu-calpain
Topics
  • Acrylates (pharmacology)
  • Animals
  • Animals, Newborn
  • Apoptosis (drug effects)
  • Calpain (antagonists & inhibitors, genetics)
  • Cardiotonic Agents (pharmacology)
  • Cell Hypoxia (drug effects)
  • Cysteine Proteinase Inhibitors (pharmacology)
  • Disease Models, Animal
  • Gene Knockdown Techniques
  • In Vitro Techniques
  • Male
  • Membrane Potential, Mitochondrial (drug effects)
  • Mice
  • Mice, Inbred C57BL
  • Mitochondria, Heart (drug effects, enzymology)
  • Mitochondrial Membrane Transport Proteins (drug effects)
  • Mitochondrial Permeability Transition Pore
  • Myocardial Reperfusion Injury (enzymology, pathology, prevention & control)
  • Myocytes, Cardiac (drug effects, enzymology, pathology)
  • RNA, Small Interfering (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: